APDN Files Provisional Patent Applications for Methods of Double-Stranded RNA Mitigation in Next-Gen mRNA Production
August 23rd, 2023
APDN Files Provisional Patent Applications for Methods of Double-Stranded RNA Mitigation in Next-Gen mRNA Production
August 23rd, 2023
LinearDNA: Alternative to Plasmid DNA for Therapeutic Applications
June 29th, 2022
Applied DNA Expands BioPharm Vertical with Two New Research Pilots of DNA Therapeutics
November 30th, 2017

Our new ticker symbol is ‘BNBX’. Learn more here.